Skip to main content

Adaptive Biotechnologies Corp

ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001478320

In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 13 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.

Q4 2025 vs. Q3 2025

How the institutions holding Adaptive Biotechnologies Corp changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ADPT: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders2712284+15
Shares145.4M306.0K150.3M+5.17M (+3.6%)
Value$2.18B$4.58M$2.44B+$270.3M (+12.5%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (53)

Institutions that held Adaptive Biotechnologies Corp at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ADPT in Q4 2025
InstitutionSharesValue% of portfolio
Westfield Capital Management Co LP4,060,481$65.9M0.27%
Nomura Asset Management International Inc.1,940,376$31.5M0.05%
PBU - The Pension Fund of Early Childhood & Youth Educators1,650,303$26.8M0.39%
StemPoint Capital LP606,825$9.85M1.69%
Balyasny Asset Management LLC426,462$6.93M0.01%
Parkman Healthcare Partners LLC401,730$6.52M0.62%
Divisadero Street Capital Management, LP361,344$5.87M0.33%
Neo Ivy Capital Management153,826$2.50M0.39%
Two Sigma Advisers, LP128,100$2.08M0.00%
HRT Financial LP124,230$2.02M0.01%
Marshall Wace, LLP112,295$1.82M0.00%
Cookson Peirce & Co Inc105,689$1.72M0.07%
1492 Capital Management LLC91,375$1.48M0.57%
Headlands Technologies LLC55,191$896.3K0.07%
Winton Group Ltd49,700$807.1K0.03%
Graham Capital Management, L.P.46,525$755.6K0.03%
Thrivent Financial for Lutherans37,934$618.0K0.00%
Integrated Quantitative Investments LLC33,005$536.0K0.12%
Harbor Capital Advisors, Inc.28,983$471.0K0.04%
Gilder Gagnon Howe & Co LLC24,998$406.0K0.00%
Y-Intercept (Hong Kong) Ltd23,777$386.1K0.01%
M&T Bank Corp21,576$349.9K0.00%
Capstone Investment Advisors, LLC20,599$334.5K0.00%
Odyssean, LLC19,560$317.7K0.23%
Alamea Verwaltungs GmbH17,030$315.1K0.21%
EntryPoint Capital, LLC18,657$303.0K0.12%
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna16,800$272.8K0.10%
Vinva Investment Management Ltd8,329$204.1K0.00%
Robeco Institutional Asset Management B.V.11,652$189.2K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC11,534$187.3K0.01%
Farallon Capital Management, L.L.C.11,000$178.6K0.00%
Bayforest Capital Ltd8,725$141.7K0.11%
Kemnay Advisory Services Inc.7,870$127.8K0.02%
Persistent Asset Partners Ltd6,689$108.6K0.05%
RiverPark Advisors, LLC3,826$62.1K0.02%
Strive Financial Group ,LLC3,180$51.6K0.03%
T. Rowe Price Investment Management, Inc.3,128$51.0K0.00%
Caitong International Asset Management Co., Ltd1,699$27.6K0.01%
Eastern Bank791$12.8K0.00%
Ares Financial Consulting, LLC715$11.6K0.01%
Los Angeles Capital Management LLC474$8.02K0.00%
Quarry LP390$6.33K0.00%
Torren Management, LLC366$5.94K0.00%
WPG Advisers, LLC158$2.57K0.00%
Optima Capital LLC65$1.06K0.00%
Breakwater Investment Management27$4390.00%
Kingdom Financial Group LLC.23$3740.00%
Atlantic Private Wealth, LLC15$2440.00%
MAI Capital Management8$1300.00%
Rachor Investment Advisory Services, LLC7$1140.00%
Northwestern Mutual Wealth Management Co4$650.00%
Byrne Asset Management LLC3$490.00%
Dunhill Financial, LLC2$240.00%

Sold out (38)

Institutions that held Adaptive Biotechnologies Corp at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (2)

Institutions that held Adaptive Biotechnologies Corp at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADPT in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Cubist Systematic Strategies, LLC290,088$4.34M
CIBC Bancorp USA Inc.15,931$238.3K